肝损伤相关指标与急重症胰腺炎病情程度及NLR比值的关系

摘要/Abstract

摘要： 目的研究肝损伤相关指标与急重症胰腺炎病情程度及中性粒细胞与淋巴细胞比值(NLR)的关系。方法收集2018年10月至2020年10月在东营市人民医院接受治疗的90例急重症胰腺炎患者的临床资料,按照病情严重程度分成中度重症急性胰腺炎(MSAP)组和重症急性胰腺炎(SAP)组,每组45例,比较两组入院时外周血ALT、AST、碱性磷酸酶(ALP)、谷氨酰转肽酶(GGT)、总胆红素(TBil)、中性粒细胞计数、淋巴细胞计数、NLR水平,通过Spearman系数分析急重症胰腺炎病情严重程度与ALT、AST、TBil、中性粒细胞计数、NLR的相关性。结果 SAP组ALT、AST、TBil水平高于MSAP组[(112.46±21.18)U/L比(84.77±14.56)U/L,(87.46±11.57)U/L比(67.16±9.16)U/L,(42.38±14.18)μmol/L比(34.58±17.89)μmol/L],差异均有统计学意义(t=7.227、9.228、7.629,均P<0.05)。SAP组中性粒细胞计数、NLR高于MSAP组[(9.27±1.07)×10⁹/L比(8.41±1.34)×10⁹/L,(8.41±2.48)比(6.18±1.04)],差异统计学意义(t=3.364、5.563,均P<0.05)。急重症胰腺炎病情严重程度与ALT、AST、TBil、中性粒细胞绝对值、NLR呈正相关(P<0.05)。结论肝损伤相关指标、NLR均可用于急重症胰腺炎病情程度的预测,且均与其存在明显相关性。

关键词: 急重症胰腺炎, 中性粒细胞与淋巴细胞比值, 肝损伤

Abstract: Objective To study the relationship between liver injury related indexes and severity of acute severe pancreatitis and neutrophil lymphocyte ratio (NLR). Methods 90 patients with severe acute pancreatitis who were treated in our hospital from October 2018 to October 2020 were included in the study, and they were divided into moderate severe acute pancreatitis (MSAP) group and severe acute pancreatitis (SAP) group according to the severity of the disease, with 45 cases in each group. The levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), glutamyl transpeptidase (GGT), total bilirubin (TBIL), absolute value of neutrophils, absolute value of lymphocytes and NLR were compared between the two groups. Spearman coefficient was used to analyze the correlation between the severity of severe acute pancreatitis and ALT, AST, TBIL, neutrophil absolute value, NLR. Results The levels of ALT, AST and TBIL in SAP group were significantly higher than those in MSAP group [(112.46±21.18) U/L vs (84.77±14.56) U/L, (87.46±11.57) U/L vs (67.16±9.16) U/L, (42.38±14.18) μmol/L vs (34.58±17.89) μmol/L]. The difference was significant (P<0.05). The absolute value and NLR of neutrophils in SAP group were significantly higher than those in MSAP group [(9.27±1.07)×10⁹/L vs (8.41±1.34)×10⁹/L, (8.41±2.48) vs (6.18±1.04)]. The difference was obvious (P<0.05). The severity of severe acute pancreatitis was positively correlated with ALT, AST, TBIL, neutrophil absolute value and NLR (P<0.05). Conclusion Liver injury related indicators and NLR can be used to predict the severity of severe acute pancreatitis, and there is a significant correlation between them.

Key words: severe acute pancreatitis, neutrophil lymphocyte ratio, liver injury

董庆莲, 李振平. 肝损伤相关指标与急重症胰腺炎病情程度及NLR比值的关系[J]. 肝脏, 2021, 26(9): 1024-1026.

DONG Qing-lian, LI Zhen-ping. Relationship between liver injury related indexes and severity of acute severe pancreatitis and NLR ratio[J]. Chinese Hepatolgy, 2021, 26(9): 1024-1026.

参考文献

[1] Cagle S D, Chopra A . Antibiotic prophylaxis for severe acute pancreatitis. Am Fam Physician,2019, 99:49-49.
[2] Bedel C , Korkut M , Selvi F . New markers in predicting the severity of acute pancreatitis in the emergency department: immature granulocyte count and percentage. J Postgrad Med, 2021, 67:7-11.
[3] 刘玉兰, 王洋. 重症急性胰腺炎致肝损伤的诊断和治疗. 中华消化杂志, 2019, 39:292-294.
[4] 易文轶,刘正金.异甘草酸镁对急性胰腺炎NF-κB通路的影响以及肝损伤的保护作用.肝脏, 2018, 23:92-94.
[5] 中华医学会外科学分会胰腺外科学组. 急性胰腺炎诊治指南(2014版). 中华消化外科杂志, 2015, 14:1-5.
[6] 陈方莹, 柏小寅, 吴东. 预测急性胰腺炎严重程度的评分系统及生物标志物. 中华内科杂志, 2019, 58:615-619.
[7] 高之峰, 王义秋, 邢飞,等. 血清C-反应蛋白/白蛋白比值对急性胰腺炎患者预后的预测作用. 徐州医学院学报, 2018, 38:571-574.
[8] 姚慧娟, 魏菲. 血清降钙素原,白细胞介素-6,超敏C反应蛋白联合检测在急性胰腺炎患者病情评估中的应用价值. 中华实验外科杂志, 2020, 37:1898-1900.
[9] 张洪领. 动态分析NLR预测急性胰腺炎严重程度及器官衰竭的临床价值. 北华大学学报:自然科学版, 2019, 20:90-94.
[10] 李洋阳, 王国兴, 张天鹏, 等. 重症急性胰腺炎合并肝功能异常患者预后的相关因素分析. 临床和实验医学杂志, 2020, 19:837-841.
[11] 何彩霞, 李鹏, 张艳婷,等. 中性粒细胞与淋巴细胞比值在急性胰腺炎并发急性肝损伤患者病情诊断中的价值. 宁夏医科大学学报, 2017, 39:429-432.
[12] 闻勇, 罗杰, 丰萍璐. 体质指数、中性粒细胞-淋巴细胞比值对急性胰腺炎病情预测价值的研究. 肝胆外科杂志, 2019, 27:289-292.
[13] 王辉, 张佳莹, 杨梦媛,等. 外周血单核细胞与淋巴细胞比值与急性胰腺炎严重程度及预后关系研究. 中国中西医结合消化杂志, 2019, 27:128-132.
[14] 郭春梅, 刘红, 台卫平,等. 重症急性胰腺炎合并胃肠功能障碍早期预测模型的建立及其应用价值. 中华危重病急救医学, 2019, 31:1264-1268.
[15] 周天昀, 潘婷婷, 刘嘉琳,等. 中性粒细胞与淋巴细胞比值在亚特兰大新分类标准下预测急性胰腺炎严重程度的价值. 上海交通大学学报:医学版, 2016, 36:1023-1028.